Efficacy and safety of the CRTh2 antagonist AZD1981 as add-on therapy to inhaled corticosteroids and long-acting β(2)-agonists in patients with atopic asthma

OBJECTIVES: To evaluate the efficacy and safety of AZD1981, a potent, specific antagonist of the CRTh2 receptor, as add-on therapy to inhaled corticosteroids (ICS) and long-acting β(2)-agonists (LABA), in patients with persistent asthma with an allergic component. PATIENTS AND METHODS: In this place...

Descripción completa

Detalles Bibliográficos
Autores principales: Bateman, Eric D, O’Brien, Christopher, Rugman, Paul, Luke, Sally, Ivanov, Stefan, Uddin, Mohib
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Clinical Trial Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5942163/
https://www.ncbi.nlm.nih.gov/pubmed/29765200
http://dx.doi.org/10.2147/DDDT.S147389

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5942163/
https://www.ncbi.nlm.nih.gov/pubmed/29765200
http://dx.doi.org/10.2147/DDDT.S147389

Ejemplares similares